Search Results - "vaccination"
Suggested Topics within your search.
Suggested Topics within your search.
- COVID-19 (Disease)
- COVID-19 33
- SARS-CoV-2 32
- COVID-19 Vaccines 28
- Vaccination 25
- Vaccines 22
- immunology 19
- Development 18
- Research 18
- prevention & control 18
- Coronavirus infections 17
- Coronavirus Infections 13
- COVID-19 Pandemic, 2020- 12
- Coronaviruses 12
- virology 12
- Betacoronavirus 11
- Immunological aspects 10
- Mutation 10
- Drug Development 9
- genetics 9
- Genetic Variation 8
- SARS-CoV-2 variants 8
- Pandemics 7
- Viral Vaccines 7
- drug effects 7
- drug therapy 6
- pathogenicity 6
- Genetics 5
- Spike Glycoprotein, Coronavirus 5
- Clinical Trials as Topic 4
-
1
Comparison of immune resilience induced by vaccination versus COVID recovery
Published 2021Table of Contents: “…Contents: The need to characterize vaccine-indued immunity in more detail -- Methods for comparison of convalescent versus vaccination-induced plasma -- Higher effectiveness of antibodies induced by mRNA vaccination -- Characteristics of the new lambda variant – implications for immune escape -- Mechanisms leading to the increased efficiency of vaccine-induced antibodies compared to those of recovered patients..…”
Get full text
Series
Electronic Audio -
2
-
3
SARS-COV-2 vaccine current biological targets and considerations /
Published 2020Table of Contents: “…Contents: Comparison of SARS-COV-2 with other coronavirus strains -- Targets for a SARS-COV-2 vaccine -- Other considerations once a vaccine has been developed.…”
Get full text
Series
Electronic Audio -
4
SARS-COV-2 vaccine development where are we now? /
Published 2020Table of Contents: “…Contents: Vaccine development for SARS-COV-2: Current position -- Different types of potential vaccines against COVID-19 -- New technologies and their implications -- How past experience can support current research.…”
Get full text
Series
Electronic Audio -
5
SARS-CoV-2 vaccine development
Published 2020Table of Contents: “…Contents: Current efforts to develop a vaccine -- Possible strategies for vaccine development -- Possible seasonal variations in virus prevalence -- When could a viable vaccine be expected?.…”
Get full text
Series
Electronic Audio -
6
The development of SARS-CoV-2 vaccines
Published 2020Table of Contents: “…Contents: Overview of three SARS-CoV-2 vaccines being developed -- Technologies being used -- Manufacturability -- Current stage of testing -- Next steps.…”
Get full text
Series
Electronic Audio -
7
mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals
Published 2021Table of Contents: “…Contents: Monitoring the levels of immune cells, e.g. memory B cells, rather than levels of antibodies, as an indication of long term immune protection -- The efficacy of vaccines in previously infected vs previously uninfected individuals -- The efficacy of a single vs double dose -- The potential value of administrating a "booster" that is different from the previous administered vaccine in an individual, AKA "mixing-and-matching".…”
Get full text
Series
Electronic Audio -
8
Emergence of blood clotting disorders resulting from COVID vaccines inoculations
Published 2021Table of Contents: “…Contents: The frequency of clotting side-effects in COVID-19 vaccines -- The characteristics of these side-effects and how they compare to other clotting disorders -- What is known regarding the mechanisms underlying these side effects -- What is known regarding populations at greater risk of suffering these side effects.…”
Get full text
Series
Electronic Audio -
9
The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports /
Published 2020Table of Contents: “…Contents: Mode of action of the Oxford/AstraZeneca RNA vaccine -- Two potential adverse events reported in patients enrolled in the vaccine's phase 3 trial -- Steps undertaken to determine possible causality between the adverse events and the vaccine -- Current status of the trial -- Please note that since the recording of this interview it was determined that "The serious adverse events observed during the trial in these study groups were judged to be unrelated to the study vaccines and occurred at frequencies expected for these conditions in the general population. …”
Get full text
Series
Electronic Audio -
10
Development of an intranasal vaccine for SARS-CoV-2
Published 2020Table of Contents: “…Contents: General mechanism of action of DNA vaccines -- Adenoviral vectors for DNA delivery to host cells -- Advantages and limitations of intranasal vaccines -- Cellular, mucosal and antibody immunity in the context of SARS-2 -- Stability of AdCOVID at room temperature -- Earliest possible approval of AdCOVID -- How far and how fast can this vaccine then be deployed?…”
Get full text
Series
Electronic Audio -
11
Human challenge trials for vaccines against COVID-19
Published 2020Table of Contents: “…Contents: Study design of human challenge trials and comparison with classical clinical trials -- Previous vaccines tested in human challenge trials -- How human challenge trials accelerate vaccine development -- Drawbacks, limitations, and potential ethical issues -- Possible COVID-19 vaccine candidates for human challenge trials.…”
Get full text
Series
Electronic Audio -
12
SARS-CoV-2 vaccine rollout campaigns
Published 2021Table of Contents: “…Contents: Overview on vaccine campaign strategies -- Challenges in a SARS-CoV-2 vaccine campaign strategy -- Identification of priority groups -- Difficulties of including priority groups into a vaccine campaign.…”
Get full text
Series
Electronic Audio -
13
Imperial College London's saRNA Vaccine - COVAC1
Published 2020Table of Contents: “…Contents: The self-amplifying RNA vaccine technology -- Current stage of the clinical trial -- Next steps in the clinical trial -- The future of the vaccine.…”
Get full text
Series
Electronic Audio -
14
Nanotechnologies in the fight against coronaviruses
Published 2020Table of Contents: “…Contents: The use of nanotechnologies in antiviral strategies, drugs, vaccines, and diagnostic tools -- Using nanotechnologies against human coronaviruses including SARS-CoV-2 -- Specific benefits of using nanotechnologies -- Carbon quantum dots.…”
Get full text
Series
Electronic Audio -
15
Tuberculosis and COVID-19
Published 2021Table of Contents: “…Contents: Similarities and differences between TB and COVID-19 -- Evidence of COVID-19 and TB co-infection -- Impact of co-infection on mortality -- Research priorities and global GTN study results -- BCG vaccine protection & COVID-19 -- Impact of COVID-19 on health services.…”
Get full text
Series
Electronic Video -
16
SARS-COV-2 what we need to know and possible future therapies /
Published 2020Table of Contents: “…Contents: SARS-COV-2 compared with other coronavirus strains -- How this comparison can help in containment, treatment, and vaccination -- Future considerations for vaccine development -- Other possible treatments for COVID-19.…”
Get full text
Series
Electronic Audio -
17
COVID-19 epidemiology and potential treatments follow up interview /
Published 2020Table of Contents: “…-- "Infectious dose" or "number of viruses" versus "viral load" -- Recent clinical trial results for SARS-2 treatments and vaccines -- Current clinical trials in Europe and the US.…”
Get full text
Series
Electronic Audio -
18
-
19
SARS-CoV-2 mutations phenotypes and implications for vaccine development /
Published 2021Table of Contents: “…Contents: Currently known SARS-CoV-2 strains -- Likelihood of mutating into a more lethal form of SARS-CoV-2 -- Spike proteins and their role in viral entry into human cells -- SARS-CoV-2 is mutating into a more transmissible or infectious form -- Implications of new SARS-CoV-2 variants on public health and vaccine development -- Importance of continuing genetic surveillance of the virus.…”
Get full text
Series
Electronic Audio -
20
SARS-CoV-2 variants implications for immunity and vaccine development /
Published 2021Subjects: Get full text
Series
Electronic Audio